Skip to main content

Table 1 Patient demographics

From: Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people

  BNT162b2 elderly cohort ChAdOx1 elderly cohort BNT162b2 younger cohort ChAdOx1 younger cohort
Number of participants 54 77 29 55
Number with Nucleocapsid-specific Antibody detected 1 3 3 5
Median age 83 83 69 72
Age Range 80–96 80–98 42–79 51–79
Age IQR 81–84 81–86 57–75 70–73
Male 24 33 12 18
Female 30 44 17 37
Time since second vaccine (Median days) 20 (IQR 18–21) 19 (IQR 18–20) 25 (20–33) 28 (19–32)